Navigation Links
German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
Date:11/28/2008

GÿRLITZ, Germany, November 28 /PRNewswire/ -- German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries. In the year 2008, 2.5 million patient tests have been performed with the portable, robust and highly affordable "CyFlow" system, supporting already more than 1 million people living with HIV/AIDS. Due to introduction of the Partec innovation, the average cost of EUR 160 per year and per patient could be reduced by a factor 20 to EUR 8, only.

The "CyFlow" instruments are being successfully used in nearly all Sub-Saharan African countries. Furthermore, the technique is being applied in Asia, Latin America, Europe and the U.S. In December 2008, the thousandth "CyFlow" device will be placed since introduction at the XVI. International AIDS Conference in Barcelona in July 2002.

By precisely measuring the CD4 T-lymphocyte concentration from blood samples, the "CyFlow" delivers accurate information about the immune status level of HIV/AIDS patients. This test is necessarily required as basis for antiretroviral therapy targeting to stabilize the immune status which is essential for survival. Approximately, 33 million people worldwide are living with HIV/AIDS. More than 95% of them reside in developing countries, especially in Africa and Asia.

On World AIDS Day 2008 Partec announces Award

On World Aids Day at 1st December, Partec announces a global award competition for NGO projects being active in the fight against HIV/AIDS. The award winner will be supported one year free of cost with the required diagnostics from Partec. Until 31st March 2009, applicants may submit a detailed project description including an explanatory statement why specifically their project should be chosen. Further information are available online at http://www.partec.com/worldaidsday. Applications should be directed by e-mail to worldaidsday@partec.com oder by telefax to +49-3581-874670.

Technologically, the "CyFlow" is based on the invention of fluorescence-based "flow cytometry" by Professor Wolfgang Gohde from German University of Munster. The worldwide first patent application in flow cytometry was filed almost exactly 40 years ago in December 1968. Since then, the key technology of Gohde has become a standard method for automated blood cell and cancer cell analysis in hospitals worldwide.

    More information:http://www.partec.com

    Media Contact:

    Partec GmbH, Germany
    Claudia Khmel
    Fax: +49-3581-8746-70
    E-Mail: c.khmel@partec.com



'/>"/>
SOURCE Partec GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
5. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
6. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
9. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
10. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
11. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):